De novo binders overcome the MMLV RT stability-activity trade-off
Moloney murine leukemia virus reverse transcriptase (MMLV RT) is an RNA-dependent DNA polymerase widely used in molecular diagnostics and gene editing. Its application is limited by poor thermal stability and inactivation induced by long-term storage. We combined multi-site mutagenesis with <i>de novo</i>-designed negatively charged protein binders targeting the nucleic acid-binding pocket to enhance stability without compromising catalysis. The engineered MMLV RT-SV variant showed improved reaction thermostability, and the addition of electrostatically complementary binders further increased intrinsic and storage stability. The resulting enzyme-binder complexes maintained full polymerase activity, exhibited a 9°C higher melting temperature, and showed minimal activity loss after accelerated aging. This study shows that <i>de novo</i>-designed binders can overcome the classical stability activity trade-off in enzymes, providing a generalizable strategy to improve biocatalysts for molecular biology and biotechnology.
Authors
- Tao Li (ORCID: https://orcid.org/0000-0001-5930-2757)
- Shujie You
- Yibo Zhu (ORCID: https://orcid.org/0000-0003-4323-1290)
- Ke Li (ORCID: https://orcid.org/0000-0002-1402-4893)
- Hongwei Liu (ORCID: https://orcid.org/0000-0002-0285-1664)
- Chunlei Ge (ORCID: https://orcid.org/0009-0004-1342-6403)
- Cuiling Wu
- Yingzhi Wang (ORCID: https://orcid.org/0000-0002-0341-4263)
- Zhonghui Wang (ORCID: https://orcid.org/0000-0001-8930-645X)
- Lin Hua (ORCID: https://orcid.org/0000-0001-9235-345X)
- Fang Qu (ORCID: https://orcid.org/0009-0009-3043-9958)
- Juanjuan Yao (ORCID: https://orcid.org/0000-0003-4128-3783)
- Hong Yao (ORCID: https://orcid.org/0000-0001-8868-3886)
Institutions
- Kunming Medical University (CN)
- First People's Hospital of Yunnan Province (CN)
- The First Hospital of Kunming (CN)
- Chongqing Medical University (CN)
- Hunan Institute of Technology (CN)
Publication Details
- Journal
- iScience
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.isci.2025.114140
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00